Catabasis Pharma (CATB) Announces Presentation of Positive MoveDMD Trial Part A Data
Tweet Send to a Friend
Catabasis Pharmaceuticals, Inc. (Nasdaq: CATB) announced that Catabasis is presenting positive data from Part A of the MoveDMD trial of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE